CHELSEA PERCY: Open Payments
NPI 1922472224 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$241 in 13 payments from 11 companies in 2025. Trend: 2023 $495 · 2024 $549 · 2025 $241
Food & beverage: $241
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $69 |
| Novo Nordisk Inc | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| Exact Sciences Corporation | 1 | $18 |
| Astellas Pharma US Inc | 1 | $18 |
| ALK-Abello, Inc | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Amphastar Pharmaceuticals, Inc. | 1 | $15 |
Products named: VRAYLAR, QULIPTA, Wegovy, XIFAXAN, The Cologuard Plus Collection Kit, Veozah, Odactra, MOUNJARO.
Industry payments across NY — which companies pay providers there.
